Title : Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation.

Pub. Date : 2015 Mar

PMID : 25523716






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. peramivir neuraminidase 1 Homo sapiens
2 Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. peramivir neuraminidase 1 Homo sapiens